We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "
H1B Visa Data Search Tool"
In-Vitro Diagnostic Substance Manufacturing (NAICS code 325413) has an average growth rate of
0.07% as an H1B industry with
379
employees hired as of 2025
The In-vitro Diagnostic Substance Manufacturing industry has been in the H1B Visa program since 2011 where 6 employees were hired. They peaked in 2023 with 42 employees, and have since been on a decline with the most recent number of employees being 14 in 2025.
The In-vitro Diagnostic Substance Manufacturing industry has been in the H1B Visa program since 2011 where the average salary was $49,299. The industry peaked in 2024 with an average salary of $102,374, and has since been on a decline with the most recent average salary being $100,448 in 2025.